PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
TI  - A Phase 3 Trial of Biologically-Based Therapy Reduction for Intermediate Risk Neuroblastoma
DP  - 2007 Sep 01
TA  - MD Conference Express
PG  - 32--34
VI  - 7
IP  - 3
4099  - http://mdc.sagepub.com/content/7/3/32.short
4100  - http://mdc.sagepub.com/content/7/3/32.full
AB  - This article reviews a phase 3 trial of biologically-based therapy reduction for intermediate risk neuroblastoma in young patients. Also discussed is a final analysis of the Head Start I and II protocols, which looked at outcome sof children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy.